MedTrace Logo

Lumigan Versus Cosopt

NCT00273455 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 34

Last updated 2008-11-19

No results posted yet for this study

Summary

To compare the intraocular pressure effect and safety of the dorzolamide/timolol fixed combination given twice daily versus bimatoprost given once every evening in patients with open-angle glaucoma in patients insufficiently controlled on latanoprost monotherapy

Conditions

  • Open-Angle Glaucoma

Interventions

DRUG

bimatoprost 0.03%

DRUG

dorzolamide 2%/timolol maleate 0.5% fixed combination

DRUG

placebo

Sponsors & Collaborators

  • Pharmaceutical Research Network

    lead OTHER

Principal Investigators

  • William C. Stewart, MD · Pharmaceutical Research Network, LLC

  • Robert D. Williams, MD · Taustine Eye Center

  • Robert H. Stewart, MD · Houston Eye Associates

  • Elizabeth D. Sharpe, MD · Glaucoma Consultants & Center for Eye Research, PA

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-01-31
Completion
2007-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00273455 on ClinicalTrials.gov